𝔖 Bobbio Scriptorium

✦ LIBER ✦

Efficacy and safety of ABT-874 versus methotrexate in patients with moderate to severe psoriasis

Book ID: 116587644
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 45 KB
Volume: 64
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2010.09.600

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ABT-874 versus etanercept and placebo in

ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Efficacy and safety results of ABT-874 v

Efficacy and safety results of ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

ABT-874 versus methotrexate in moderate

ABT-874 versus methotrexate in moderate to severe psoriasis: Effects on health-related quality-of-life outcomes

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Adding methotrexate to etanercept versus

Adding methotrexate to etanercept versus etanercept monotherapy in adults with moderate to severe plaque psoriasis: Efficacy and safety

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Health-related quality of life outcomes

Health-related quality of life outcomes in patients with moderate to severe psoriasis treated with ABT-874 versus etanercept or placebo

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Health-related quality of life in patien

Health-related quality of life in patients with moderate to severe psoriasis: Effects of treatment with ABT-874 versus etanercept or placebo

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB